Brief: Mayne Pharma Group Says Expects 1H FY25 Revenues To Be A$210 - A$215 Million
10/02/2025 01:29
Feb 10 (Reuters) - Mayne Pharma Group Ltd MYX.AX :
* EXPECTS 1H FY25 REVENUES TO BE A$210 - A$215 MILLION
* SEES 1H FY25 UNDERLYING EBITDA1 OF A$30 - A$32 MILLION
Further company coverage: MYX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)